201 related articles for article (PubMed ID: 17335357)
1. A managed care organization's use of integrated health management to improve secondary prevention of coronary artery disease.
Berthiaume JT; Davis J; Taira DA; Thein KK
Am J Manag Care; 2007 Mar; 13(3):142-7. PubMed ID: 17335357
[TBL] [Abstract][Full Text] [Related]
2. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
[TBL] [Abstract][Full Text] [Related]
4. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
[TBL] [Abstract][Full Text] [Related]
5. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
6. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program.
Lewis WR; Ellrodt AG; Peterson E; Hernandez AF; LaBresh KA; Cannon CP; Pan W; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):633-41. PubMed ID: 20031902
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
Banasiak W; Wilkins A; Pociupany R; Ponikowski P
Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
[TBL] [Abstract][Full Text] [Related]
8. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.
Newby LK; LaPointe NM; Chen AY; Kramer JM; Hammill BG; DeLong ER; Muhlbaier LH; Califf RM
Circulation; 2006 Jan; 113(2):203-12. PubMed ID: 16401776
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
10. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
[TBL] [Abstract][Full Text] [Related]
11. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the quality of care for patients with coronary heart disease: the design and baseline results of the hastening the effective application of research through technology (HEART) trial.
Goff DC; Gu L; Cantley LK; Parker DG; Cohen SJ
Am J Manag Care; 2002 Dec; 8(12):1069-78. PubMed ID: 12500883
[TBL] [Abstract][Full Text] [Related]
13. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
Granmyr J; Ball P; Curran S; Wang L
Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
[TBL] [Abstract][Full Text] [Related]
15. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
Goff DC; Massing MW; Bertoni AG; Davis J; Ambrosius WT; McArdle J; Duren-Winfield V; Sueta CA; Croft JB
Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy after myocardial infarction: disease management versus usual care.
Chan V; Cooke CE
Am J Manag Care; 2008 Jun; 14(6):352-8. PubMed ID: 18554073
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
[TBL] [Abstract][Full Text] [Related]
19. Use of secondary preventive medications after the first attack of acute coronary syndrome.
Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
[TBL] [Abstract][Full Text] [Related]
20. Regional variation in medication following coronary events in Germany.
Müller-Nordhorn J; Kulig M; Binting S; Völler H; Krobot KJ; Willich SN
Int J Cardiol; 2005 Jun; 102(1):47-53. PubMed ID: 15939098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
